LIPELLA PHARMACEUTICALS INC (LIPO)
US53630L1008 - Common Stock
| TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -4.14M | -4.62M | -2.60M | -1.87M | -61.66K | |||
| Depreciation Amortization | N/A | 1.69K | N/A | N/A | N/A | |||
| Change In Working Capital | -494.29K | -9.11K | 9.52K | 197.61K | -32.28K | |||
| Interest Paid | 2.48K | 11.36K | 0.00 | 0.00 | 0.00 | |||
| Taxes Paid | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | 909.27K | 1.48M | 757.01K | 678.59K | 65.36K | |||
| OPERATING CASH FLOW | -3.72M | -3.15M | -1.83M | -989.27K | -28.58K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -14.43K | N/A | N/A | N/A | |||
| Other Investing Activity | N/A | 0.00 | 300.55K | -300.55K | 0.00 | |||
| INVESTING CASH FLOW | N/A | -14.43K | 300.55K | -300.55K | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -275.00K | 275.00K | 0.00 | 57.04K | |||
| Stock Issued/Repurchased | N/A | 1.61M | 4.96M | 2.10M | 552.27K | |||
| FINANCING CASH FLOW | 1.81M | 1.34M | 5.24M | 2.10M | 609.31K | |||
| CHANGE IN CASH | -1.93M | -1.83M | 3.71M | 807.09K | 580.73K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -3.72M | -3.15M | -1.83M | -989.27K | -28.58K | |||
| Capital Expenditure | N/A | -14.43K | N/A | N/A | N/A | |||
| FREE CASH FLOW | -3.74M | -3.16M | -1.83M | -989.27K | -28.58K | |||
All data in USD